Medicines / Glaxosmithkline Pharmaceuticals / Nucala
NucalaMepolizumab
Nucala is marketed by Glaxosmithkline Pharmaceuticals. 1 pack on NPPA's price list for July 2026, containing Mepolizumab.
- Packs listed
- 1
- Lowest MRP
- ₹62,000
- Per unit
- ₹62,000
- Price-controlled packs
- 0 of 1
- Dosage forms
- 1
Packs and prices
- ₹62,000Nucala 100 mg Injection 1 mlMepolizumab Injection 100 mg · ₹62,000 per ml
The same composition from other brands
Packs with the identical filed composition, form and strength. A different brand is not automatically interchangeable: ask your doctor or pharmacist.
Mepolizumab Injection 100 mg
- ₹7,985/mlNucala FD · 10 ml injectionGlaxosmithkline Pharmaceuticals · MRP ₹79,853
1 other brand of this composition on the price list; the 1 lowest per ml are shown. All Mepolizumab packs
The company
Glaxosmithkline Pharmaceuticals has 385 packs on the price list, and CDSCO has named it as the manufacturer of 5 failed batches since Oct 2019. Company record
Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.